论文部分内容阅读
目的:探究中药汤剂丹栀逍遥散辅助治疗慢性盆腔炎患者的临床疗效。方法:对2013年12月—2015年2月被确诊为慢性盆腔炎的200例患者的临床资料和实验室数据进行分析,依据计算机分组,随机分为实验组和对照组各100例,对照组联合用药进行治疗,药物选择丹红注射液配合抗生素;实验组则在此联合用药的基础上,再配合丹栀逍遥散进行辅助治疗。比较两组治疗后的临床疗效,进行评估及对比。结果:依据临床效果的结果显示,实验组显效率50.00%,有效率为48.00%,总有效率为98.00%,对照组显效为30.00%,有效率为55.00%,总有效率为85.00%,实验组的治疗效果显著高于对照组,存在显著差异,具有可比性,具有统计学意义(P<0.05);依据不良反应发生状况分析,实验组8例一次性高热;对照组5例阴道瘙痒,3例轻度丘疹,两组不良反应发生率一致,为8.00%,没有显著差异,无统计学意义(P>0.05),未发生严重的不良反应。结论:中医妇产科采用丹栀逍遥散对慢性盆腔炎进行辅助治疗,疗效确切且显著,安全性良好,配合基础常规的治疗可以有效地提高临床疗效,避免不良反应的发生,值得临床进一步研究和推广。
Objective: To investigate the clinical curative effect of Chinese medicine decoction Dan Zhi Xiaoyao San in the treatment of patients with chronic pelvic inflammatory disease. Methods: The clinical data and laboratory data of 200 patients diagnosed as chronic pelvic inflammatory disease between December 2013 and February 2015 were analyzed. According to the computer grouping, 100 patients in experimental group and control group were randomly divided into control group Combination therapy for treatment, drug selection Danhong injection with antibiotics; experimental group is based on the combination of medication, and then with Dan Zhi Xiaoyaosan adjuvant therapy. The clinical efficacy of the two groups after treatment was compared, evaluated and compared. Results: According to the clinical results, the effective rate of the experimental group was 50.00%, the effective rate was 48.00%, the total effective rate was 98.00%, the control group was 30.00%, the effective rate was 55.00% and the total effective rate was 85.00% The treatment group was significantly higher than the control group, there were significant differences, comparable, statistically significant (P <0.05); based on the analysis of adverse reactions, experimental group of 8 cases of high fever; control group of 5 cases of vaginal itching, 3 cases of mild papules, the incidence of adverse reactions in both groups was 8.00%, no significant difference, no statistical significance (P> 0.05), no serious adverse reactions. Conclusion: Obstetrics and Gynecology Danzhixiaoyao San on chronic pelvic inflammatory disease adjuvant therapy, the effect is clear and significant, good safety, with the basis of conventional treatment can effectively improve the clinical efficacy, to avoid adverse reactions, it is worth further clinical study And promotion.